# Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Study · id `cardio:ct-nct01508910` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01508910](<https://clinicaltrials.gov/study/NCT01508910>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01508910

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 291 participants.

## Technical summary

Registry record NCT01508910. Randomized; double masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2015-11 (actual). Results posted on 2017-02-15.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 291 participants (enrolled count; ClinicalTrials.gov record NCT01508910, source copy `cardio:ctgov-nct01508910-2018-12-19`, retrieved 2026-11-18)
- Start date: 2012-04 (registry gives no type) (ClinicalTrials.gov record NCT01508910, source copy `cardio:ctgov-nct01508910-2018-12-19`, retrieved 2026-11-18)
- Primary completion: 2015-11 (actual) (ClinicalTrials.gov record NCT01508910, source copy `cardio:ctgov-nct01508910-2018-12-19`, retrieved 2026-11-18)
- Completion: 2015-11 (actual) (ClinicalTrials.gov record NCT01508910, source copy `cardio:ctgov-nct01508910-2018-12-19`, retrieved 2026-11-18)
- Results first posted: 2017-02-15 (ClinicalTrials.gov record NCT01508910, source copy `cardio:ctgov-nct01508910-2018-12-19`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT01508910, source copy `cardio:ctgov-nct01508910-2018-12-19`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01508910-2018-12-19`, retrieved 2026-11-18)

## The registry's words

- Brief title: Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
- Acronym: RENEW
- Condition: Chronic Myocardial Ischemia
- Condition: Refractory Angina Pectoris
- Condition: Advanced Coronary Heart Disease
- Intervention (Biological): Auto-CD34+ cells
- Intervention (Biological): Placebo: Diluent used to suspend Auto-CD34+ cells
- Intervention (Other): Standard of care
- Lead sponsor: Lisata Therapeutics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina (`cardio:pubmed-27491607`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a10aaf3f25a947a1eedc3836974e2944154e8d2baaf2a0f86a0c9a93f7933521
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
